Best Stocks To Buy Right Now

Hanover, MA, based Investment company Bright Rock Capital Management, Llc buys Halliburton Co, AMETEK Inc, Watsco Inc, General Mills Inc, Oceaneering International Inc, sells Schlumberger, Acuity Brands Inc, Stericycle Inc, EQT Corp during the 3-months ended 2017-12-31, according to the most recent filings of the investment company, Bright Rock Capital Management, Llc. As of 2017-12-31, Bright Rock Capital Management, Llc owns 80 stocks with a total value of $312 million. These are the details of the buys and sells.

New Purchases: HAL, AME, WSO, Added Positions: CVS, GIS, OII, Reduced Positions: SLB, WMT, CVX, SHW, EQT, RHT, Sold Out: AYI, SRCL,

For the details of BRIGHT ROCK CAPITAL MANAGEMENT, LLC’s stock buys and sells, go to

These are the top 5 holdings of BRIGHT ROCK CAPITAL MANAGEMENT, LLCThe Home Depot Inc (HD) – 57,100 shares, 3.46% of the total portfolio. Shares added by 0.18%Wells Fargo & Co (WFC) – 174,215 shares, 3.38% of the total portfolio. Shares added by 0.12%Verizon Communications Inc (VZ) – 189,175 shares, 3.2% of the total portfolio. Shares added by 0.09%Chevron Corp (CVX) – 77,000 shares, 3.09% of the total portfolio. Shares reduced by 8.33%Union Pacific Corp (UNP) – 69,500 shares, 2.98% of the total portfolio. New Purchase: Halliburton Co (HAL)

Bright Rock Capital Management, Llc initiated holdings in Halliburton Co. The purchase prices were between $41.02 and $48.87, with an estimated average price of $44.12. The stock is now traded at around $53.38. The impact to the portfolio due to this purchase was 1.33%. The holdings were 85,000 shares as of 2017-12-31.

Best Stocks To Buy Right Now: MGC Diagnostics Corporation(MGCD)

Advisors’ Opinion:

  • [By Monica Gerson]

    MGC Diagnostics Corp (NASDAQ: MGCD) is projected to post earnings for the latest quarter.

    Lands’ End, Inc. (NASDAQ: LE) is estimated to report its quarterly earnings at $0.02 per share on revenue of $293.24 million.

  • [By Lisa Levin]

    MGC Diagnostics Corp (NASDAQ: MGCD) shares shot up 24 percent to $10.92 after the company agreed to be acquired by Altus Capital Partners for $11.03 per share in cash.

  • [By Lisa Levin]

    MGC Diagnostics Corp (NASDAQ: MGCD) shares shot up 24 percent to $10.94 after the company agreed to be acquired by Altus Capital Partners for $11.03 per share in cash.

Best Stocks To Buy Right Now: Fiat Chrysler Automobiles N.V.(FCAM)

Advisors’ Opinion:


    The showstopper by far in the early going is Waymo’s self-driving minivan (pictured below) in partnership with Fiat Chrysler (FCAM) . Waymo’s ultimate mom-mobile, coming from a business that was spun-off from Google’s parent company Alphabet Inc. (GOOG) last month, is equipped with self-driving sensors and vision systems.

Best Stocks To Buy Right Now: Golfsmith International Holdings Inc.(GOLF)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Tuesday, our Under the Radar Moversnewsletter suggestedshorting small cap golf equipment stockAcushnet Holdings Corp (NYSE: GOLF):

    Acushnet Holdings has been on our watchlist for a while too, but it’s only been in the past few days we’ve seen the cracks start to appear.

Best Stocks To Buy Right Now: Spark Therapeutics, Inc.(ONCE)

Advisors’ Opinion:

  • [By Paul Ausick]

    Spark Therapeutics Inc. (NASDAQ: ONCE) dropped 44% Monday to post a new 52-week low of $41.06 after closing at $73.38 on Friday. The 52-week high is $91.75. Volume was around 13.5 million, nearly 30 times the daily average of about 480,000. The company’s hemophilia A drug posted disappointing trial results.

  • [By Lisa Levin]

    Shares of Spark Therapeutics Inc (NASDAQ: ONCE) were down 36 percent to $47.08 on preliminary SPK-8011 trial data.

    Athenex Inc (NASDAQ: ATNX) was down, falling around 13 percent to $13.95. Almirall and Athenex reported a strategic partnership to develop and commercialize KX2-391 in the U.S. and Europe.

  • [By Jim Robertson]

    On Wednesday, our Elite Opportunity Pronewsletter suggested going long again on small cap gene therapy stock Spark Therapeutics (NASDAQ: ONCE):

    Financially, Spark Therapeutics has over $300M in cash on the books and no debt to speak of yet, which equates to a share price of just over four times cash. The Company has generated over $20M in revenue for the trailing twelve months, and although the Company is expected to continue to lose money for the next few years, any strong clinical data that hits the tape could rocket shares of ONCE overnight, just like we’ve seen with so many others over the years.

  • [By Chris Lange]

    Spark Therapeutics Inc. (NASDAQ: ONCE) saw its shares take a big step back on Monday after the firm reported less than favorable results at the American Society of Hematology (ASH) annual meeting. Analysts have taken this opportunity to weigh in on the stock:

  • [By Logan Wallace]

    Spark Therapeutics (NASDAQ:ONCE) was the target of some unusual options trading activity on Thursday. Investors acquired 551 put options on the company. This represents an increase of 884% compared to the average volume of 56 put options.

  • [By Tyler Crowe, Dan Caplinger, and Cory Renauer]

    Doubling your money in a relatively short time is much tougher. It typically involves investing in younger, less established companies that have lots of growth potential but could give a lot of ground if a few things don’t swing their way. There are, though, some stocks that look like they have a double in them over a relatively short time frame, and three of our investing contributors think Spark Therapeutics (NASDAQ:ONCE), Tractor Supply (NASDAQ:TSCO), and American Tower (NYSE:AMT) fit the bill.

Best Stocks To Buy Right Now: Eagle Materials Inc(EXP)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares fell by 1.10 percent. Meanwhile, top losers in the sector included Mechel PAO (ADR) (NYSE: MTL), down 8 percent, and Eagle Materials, Inc. (NYSE: EXP), down 6 percent.

  • [By David Sterman]

    Of course, in many cyclical industries, it’s impossible to maintain very strong growth rates when the economy slumps. And that was a lesson learned by Eagle Materials (NYSE: EXP(link is external)), a maker of drywall, cement and other materials used in homebuilding. Eagle experienced solid growth a decade ago, but when the housing market tanked, so did Eagle’s revenue base. Sales fell by half from fiscal 2007 through fiscal 2011 (to around $460 million).

    Yet even before the pace of home construction returns to normal levels, Eagle is again experiencing solid growth: Sales are now growing at a 30% pace and are expected to surpass $1.1 billion in the current fiscal year, which began this month. That’s 25% higher than the peak in fiscal 2007, and it’s setting the stage for solid profit growth: Earnings per share (EPS) are growing at a 50% pace these days, a pace which could be sustained for an extended period if the housing market finally starts to grow at a solid clip. 

  • [By ]

    What’s most compelling about Cemex is the fact that it’s hands down the cheapest stock in the group. While Martin Marietta (NYSE: MLM), Eagle Materials (NYSE: EXP) and Vulcan Materials (NYSE: VMC) trade at 34, 24 and 45 times earnings, CX trades at just 13.44, with a forward PEG ratio of just 0.55…